Kao Continues to be Included in All of the ESG Indices Used by the Government Pension Investment Fund (GPIF)

Status of Repurchase of the Company's Stock (Stock Repurchase in accordance with Articles of Incorporation pursuant to Article 165, paragraph 2 of the Companies Act)

Kao Releases Progress Reports on its ESG Strategy—the Kirei Lifestyle Plan

Kao Releases the Kao Integrated Report 2022

Kao to Participate in a Recycling Field Test for Building a Used Packaging Collection Platform by the Japan Association of Chain Drug Stores

Kao Launches Bioré GUARD Mos Block Serum* , a Newly-developed Mosquito Repellent Product, in Thailand

Kao to Open Official Account for the Prestige Brand KANEBO on China's Leading Short-Form Videos Platform

Status of Repurchase of the Company's Stock (Stock Repurchase in accordance with Articles of Incorporation pursuant to Article 165, paragraph 2 of the Companies Act)

Kao Participates in Cosme Bank Project as a Board Member Company

Consolidated Financial Results for the Three Months Ended March 31, 2022 [IFRS] (Jan. 1, 2022 - Mar. 31, 2022)

Repurchase of the Company's Stock (Stock Repurchase in accordance with Articles of Incorporation pursuant to Article 165, paragraph 2 of the Companies Act)

Entries Now Open for the Thirteenth Kao International Environment Painting Contest for Children

Accelerating Efforts Toward Carbon Zero by 2040 and Carbon Negative By 2050

Kao and Nissin Agree to Collaborate to Utilize the Virtual Human Body Generative Model

Progress of Helping Oil Palm Smallholders in Indonesia

Kao Publishes Its Web Accessibility Policy Targeting the International Standard "WCAG" Version 2.1 Level AA

Kao and Lion Awarded the New Selection Committee Chairman's Commendation in the Good Practices of Consumer-Oriented Management Awards

Kao to Establish New Flexible, Efficient Production System and Logistics Model at Toyohashi Plant

SENSAI Introduces ABSOLUTE SILK ILLUMINATIVE CREAM An Anti-Ageing1 Cream with the Subtle lustre of Koishimaru Silk

Kao Revises the Kao Group Health Declaration